Clinical Trial Research
Cobalis Completes Funding; Expects Top-Line Phase III Trial Results for PreHistin in April 2007
Published in Law and Health Weekly, April 7th, 2007
Cobalis Corp. (OTC BB: CLSC) a pharmaceutical development company specializing in anti-allergy medications, announced that it has completed its $3.85 million funding with the receipt of gross proceeds of $675,000 from the third and final closing under its Security Purchase Agreement dated December 20, 2006. The final closing was funded after the Securities and Exchange Commission declared the Company's related Registration Statement was effective.
A portion of the proceeds from the third closing will be utilized to complete data analysis required for reporting top-line efficacy results from the Company's twin pivotal Phase III Clinical Trials for its anti-allergy...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Advanced Medical Optics, Inc.
Advanced Medical Optics, Inc. Announces Offering of Senior Subordinated Notes - Alcoholism
New alcoholism study findings recently were published by researchers at RTI International - American Medical Informatics Association
AMIA AND AHIMA Announce Support for 10,000 Trained by 2010 Act (H.R. 1467) - AMERIGROUP Corporation
AMERIGROUP Announces Offering of $200 million in Convertible Senior Notes - Anthrax
VaxGen Files Notice of Appeal Regarding Cancelled Anthrax Contract - Bausch & Lomb
Bausch & Lomb Names Efrain Rivera Senior Vice President and Chief Financial Officer, Succeeding Stephen C. McCluski Who Will Retire June 30, 2007 - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
